Sirolimus may promote thrombotic microangiopathy.
Saikali
Jocelyne A
JA
Depajtments of Pathology and Medicine, The Methodist Hospital and Baylor College of Medicine, Houston, Texas, USA.
Truong
Luan D
LD
Suki
Wadi N
WN
D000328:Adult; D044383:Black People; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D016030:Kidney Transplantation; D020123:Sirolimus / Q000009:adverse effects*; D016559:Tacrolimus / Q000627:therapeutic use; D013927:Thrombosis / Q000139:chemically induced* / Q000175:diagnosis / Q000628:therapy; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D020123:Sirolimus; D016559:Tacrolimus